Transfer pricing comparables and corrected margins led to exclusion of an unsuitable benchmark and removal of the adjustment.

A comparable company must be excluded where its functions, assets, risks and product profile are materially different from those of the tested party; IDS Denmed Private Limited was therefore rejected as a benchmark for a limited risk distributor trading in healthcare products. Comparable margins also had to be recomputed where the annual report data showed that the transfer pricing officer used incorrect financial figures; the corrected margins were accepted for benchmarking. On that basis, the arm's length range covered the assessee's margin and the transfer pricing adjustment was eliminated. The remaining grounds were treated as academic.

---

---

Issues: (i) whether IDS Denmed Private Limited was a valid comparable for benchmarking the international transaction of purchase of healthcare products for resale; (ii) whether the operating profit margins of selected comparable companies required correction on the basis of the annual report data, so as to alter the arm's length range and the transfer pricing adjustment.

Issue (i): whether IDS Denmed Private Limited was a valid comparable for benchmarking the international transaction of purchase of healthcare products for resale.

Analysis: The assessee functioned as a limited risk distributor, whereas the impugned comparable was engaged in manufacturing surgical instruments and had no comparable segmental profile. The functions performed, asset base, and risk profile were materially different, and the product profile was also not similar to the assessee's trading activity in health imaging products. The revenue did not rebut the factual distinction.

Conclusion: IDS Denmed Private Limited was directed to be excluded from the final set of comparables, in favour of the assessee.

Issue (ii): whether the operating profit margins of selected comparable companies required correction on the basis of the annual report data, so as to alter the arm's length range and the transfer pricing adjustment.

Analysis: The assessee furnished corrected working of margins for certain comparables, supported by annual report extracts, showing that the margins adopted by the transfer pricing officer were not computed on the correct financial data. The corrected figures were found to be reliable and were directed to be considered for benchmarking.

Conclusion: The transfer pricing officer was directed to recompute the margins on the corrected financial data, which resulted in an arm's length range covering the assessee's margin and eliminating the transfer pricing adjustment, in favour of the assessee.

Final Conclusion: The appeal succeeded on the substantive transfer pricing issues, while the remaining grounds were treated as academic and not separately adjudicated.

Ratio Decidendi: A comparable company must be excluded where its functions, assets, risks, and product profile are materially dissimilar to those of the tested party, and benchmarking must proceed on correctly computed comparable margins supported by reliable record data.

---